Cargando…

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

Neuroblastoma (NB) is the most common extracranial solid tumor in children. Aberrant activation of the non-receptor tyrosine kinases Src and c-Abl contributes to the progression of NB. Thus, targeting these kinases could be a promising strategy for NB therapy. In this paper, we report that the poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bieerkehazhi, Shayahati, Chen, Zhenghu, Zhao, Yanling, Yu, Yang, Zhang, Huiyuan, Vasudevan, Sanjeev A., Woodfield, Sarah E., Tao, Ling, Yi, Joanna S., Muscal, Jodi A., Pang, Jonathan C., Guan, Shan, Zhang, Hong, Nuchtern, Jed G., Li, Hui, Li, Huiwu, Yang, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352070/ https://www.ncbi.nlm.nih.gov/pubmed/27903968 http://dx.doi.org/10.18632/oncotarget.13643

Ejemplares similares

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
por: Rassi, Fuad El, et al.
Publicado: (2013)

Bosutinib: A Novel Src/Abl Kinase Inhibitor for Chronic Myelogenous Leukemia
por: Steinbach, Alison, et al.
Publicado: (2013)

Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo
por: Chen, Zhenghu, et al.
Publicado: (2017)

A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M, et al.
Publicado: (2006)

Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M., et al.
Publicado: (2012)

Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src kinases
por: Fernow, Inga, et al.
Publicado: (2009)

Src and Abl hijack the Robo1 pathway
por: Naus, Christian
Publicado: (2010)

Computational Study of the “DFG-Flip” Conformational Transition in c-Abl and c-Src Tyrosine Kinases
por: Meng, Yilin, et al.
Publicado: (2014)

Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration
por: Fowler, Alan J., et al.
Publicado: (2019)

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection
por: Ullah, Imran, et al.
Publicado: (2023)

Cortactin Is Required for Efficient FAK, Src and Abl Tyrosine Kinase Activation and Phosphorylation of Helicobacter pylori CagA
por: Knorr, Jakob, et al.
Publicado: (2021)

CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families
por: Krisch, Linda M., et al.
Publicado: (2016)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Src activates Abl to augment Robo1 expression in order to promote tumor cell migration
por: Khusial, P. Raaj, et al.
Publicado: (2010)

Knocking Down Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP) Reverts Chemoresistance through Inactivation of Src and Bcr-Abl Proteins
por: Ferreira, Paula A., et al.
Publicado: (2012)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma
por: Mao, Xinfang, et al.
Publicado: (2016)

The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines
por: Gwanmesia, Patricia Mambou, et al.
Publicado: (2009)

Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo
por: Li, Haoyu, et al.
Publicado: (2016)

Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model
por: Scott, Aaron J., et al.
Publicado: (2017)

VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation
por: Fantin, Alessandro, et al.
Publicado: (2017)

Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis
por: Chen, Zhenghu, et al.
Publicado: (2016)

Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis
por: Nieborowska-Skorska, Malgorzata, et al.
Publicado: (1999)

Nuclear Functions of the Tyrosine Kinase Src
por: Bagnato, Giulia, et al.
Publicado: (2020)

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2017)

EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma
por: Sun, Wenjing, et al.
Publicado: (2017)

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
por: Uz, B., et al.
Publicado: (2011)

Auto-thiophosphorylation activity of Src tyrosine kinase
por: Cabail, M. Zulema, et al.
Publicado: (2016)

Crosstalk Between BCR/ABL Oncoprotein and CXCR4 Signaling through a Src Family Kinase in Human Leukemia Cells
por: Ptasznik, Andrzej, et al.
Publicado: (2002)

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
por: Woodcock, Victoria K, et al.
Publicado: (2018)

SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia
por: Sarno, Jolanda, et al.
Publicado: (2018)

Locking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPV
por: Yasmeen, Amber, et al.
Publicado: (2010)

Src stimulates Abl-dependent phosphorylation of the guanine exchange factor Net1A to promote its cytosolic localization and cell motility
por: Sprenger, Ashabari, et al.
Publicado: (2023)

Src-homology domain 2 containing protein tyrosine phosphatase-1 (SHP-1) directly binds to proto-oncogene tyrosine-protein kinase Src (c-Src) and promotes the transcriptional activation of connexin 43 (Cx43)
por: Liu, YiHao, et al.
Publicado: (2022)

Effect of Src tyrosine kinase on a rat model of asthma
por: Wu, Min, et al.
Publicado: (2022)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
por: Takeuchi, Asako, et al.
Publicado: (2020)

Regulation of Fibroblast Cell Polarity by Src Tyrosine Kinase
por: Katoh, Kazuo
Publicado: (2021)

Abl Is Able to Inhibit Cell Engulfment
por: Robinson, Richard
Publicado: (2009)

Molecular Characterization of c-Abl/c-Src Kinase Inhibitors Targeted against Murine Tumour Progenitor Cells that Express Stem Cell Markers
por: Kruewel, Thomas, et al.
Publicado: (2010)

Constitutive Activity in an Ancestral Form of Abl Tyrosine Kinase
por: Aleem, Saadat U., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_daubv2kcrvk4p4n7di1f64b9h2